Serious Chronic Lung Disease Gets First FDA-Approved Drug

(MedPage Today) — The FDA approved oral brensocatib (Brinsupri) as the first treatment for non-cystic fibrosis bronchiectasis in adults and kids 12 years and up, drugmaker Insmed announced on Tuesday.
A first-in-class reversible dipeptidyl peptidase…